Welcome to our dedicated page for Schwab (CHARLES) (The) SEC filings (Ticker: SCHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Charles Schwab Corporation (NYSE: SCHW) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its financial condition, capital structure, and material events. This page aggregates Schwab’s SEC filings and pairs them with AI-powered summaries to help readers understand the key points in lengthy regulatory documents.
For Schwab, core filings include annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its brokerage, banking, asset management, custody, and financial advisory operations, along with risk factors, management’s discussion and analysis, and segment information. Current reports on Form 8-K disclose specific events, such as quarterly earnings releases, the issuance of senior notes under a shelf registration statement, and definitive agreements for acquisitions like the announced agreement to acquire Forge Global Holdings, Inc.
Schwab also maintains registration statements, such as its Form S-3 shelf registration used for offerings of senior notes and other securities, and exhibits that include underwriting agreements, indentures, supplemental indentures, and legal opinions. Filings related to its listed securities cover its common stock and depositary shares representing interests in preferred stock series that trade on the New York Stock Exchange.
On this page, users can quickly access new and historical filings, including 10-K and 10-Q reports, 8-K current reports, and other registration and exhibit documents. AI-generated overviews highlight important disclosures, summarize complex capital markets transactions, and clarify technical language, while links to Form 4 and other ownership reports make it easier to review insider transactions and equity awards. Real-time updates from EDGAR ensure that investors, analysts, and researchers can review Schwab’s regulatory history and recent disclosures in one organized location.
Schwab (SCHW) filed a Form 144 notice for a proposed sale of 44,750 shares of common stock, with an aggregate market value of $4,206,500. The approximate sale date is 10/29/2025 on the NYSE, and the broker listed is The Charles Schwab Corporation, 3000 Schwab Way, Westlake, TX. The filing identifies Charles R. Schwab as the person for whose account the securities are to be sold. Shares outstanding were 1,815,219,300 at the time reported in the notice.
The seller reported prior sales over the past three months, including 22,721 shares on 08/07/2025 for $2,181,610 and 133,153 shares on 08/08/2025 for $12,888,080, alongside additional transactions on 08/26/2025, 08/27/2025, and 10/28/2025. The signatory represents they do not know any material adverse nonpublic information regarding the issuer.
The Charles Schwab Corporation (SCHW): Charles R. Schwab filed a Form 144 notice to sell up to 64,400 shares of common stock, with an approximate sale date of 10/28/2025. The filing lists an aggregate market value of $6,053,600. Shares outstanding were 1,815,219,300. He also reported recent sales in August 2025, including 22,721 shares on 08/07/2025 for $2,181,610 and 133,153 shares on 08/08/2025 for $12,888,080.
Charles Schwab Corp (SCHW) insider filing: the Co‑Chairman and Director reported two gift transactions of common stock. On 10/23/2025, a gift of 18,595 shares was reported at $0 per share, followed by a gift of 31,750 shares on 10/24/2025, also at $0, each reported as indirect ownership by trust.
Following these transactions, beneficial ownership by trust is reported as 56,281,104 shares. Additional indirect holdings are listed as 9,509,797.33 shares by spouse as trustee, 30,641,981 shares by a limited partnership, and 44,025 shares by 188 Corp.
The Charles Schwab Corporation announced it issued a press release with financial results for the quarter ended September 30, 2025. The release was furnished as Exhibit 99.1 to the report.
This notice is an administrative update that makes Schwab’s quarterly results publicly available through an accompanying press release. The filing also lists the company’s registered securities, including common stock (SCHW) and depositary shares for Series D and Series J preferred stock.
Charles Schwab (SCHW) reported a director equity award. On 10/01/2025, the director acquired 407 restricted stock units (RSUs) under the Directors’ Deferred Compensation Plan II, held in a rabbi trust and received in lieu of cash director fees. The RSUs are distributed when she leaves the Board. After the transaction, RSU holdings were 6,950.79, including 18.40 acquired through dividend reinvestment.
Stephen A. Ellis, a Director of Schwab Charles Corp (SCHW), was granted 366 restricted stock units (RSUs) on 10/01/2025 under the Directors' Deferred Compensation Plan II and received them in lieu of cash director fees. The RSUs are held in a rabbi trust for the reporting person and will be distributed when he leaves the Board. After the grant the filing reports 12,025.42 shares beneficially owned by Mr. Ellis, which includes 32.78 RSUs acquired through dividend reinvestment. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 10/03/2025.
Charles Schwab Corporation (SCHW) reported a Form 4 showing a director received a nonqualified stock option to buy 1,340 shares at $92.25 on 10/01/2025. The option vests immediately and expires on 10/01/2035.
The award was granted under the Directors' Deferred Compensation Plan II in lieu of cash director fees. After this transaction, the director beneficially owns 1,340 derivative securities, reported as direct (D) ownership.
Frank C. Herringer, a director of Schwab Charles Corp (SCHW), reported awards received on 10/01/2025. He was granted 224 restricted stock units (RSUs) under the Directors' Deferred Compensation Plan II, held in a rabbi trust and payable when he leaves the board; the filing notes those RSUs were issued in lieu of cash director fees. The report also shows a nonqualified stock option for 921 shares with an exercise price of $92.25, exercisable immediately and expiring on 10/01/2035, which was likewise issued in lieu of cash fees. The filing discloses total beneficial ownership following the transactions of 149,911.14 shares and that the RSU total includes 420.79 RSUs acquired through dividend reinvestment.
Carolyn Schwab-Pomerantz, a director of SCHWAB CHARLES CORP (SCHW), reported sales of company common stock under a Rule 10b5-1 trading plan. On 10/02/2025 she disposed of 14,400 shares at a weighted-average price of $92.5465 and 9,600 shares at a weighted-average price of $92.5545, each sale effected in multiple trades. The filing states the 10b5-1 plan was adopted on August 14, 2024. Following the reported transactions the form lists various beneficial holdings, including 1,434,856.6599 shares indirectly held by a trust and 440,914 shares indirectly held by spouse as trustee; additional holdings of 9,624 and 2,798 shares are also reported with direct or indirect forms. The report is signed by an attorney-in-fact on 10/03/2025.
Paul V. Woolway, MD, Chief Banking Officer of Schwab Charles Corp (SCHW), reported multiple sales of company common stock on 10/01/2025. The Form 4 shows two Rule 10b5-1 plan sales of 1,913 and 1,292 shares (both marked S(1)) and another reported disposal of 25,153 shares. The reporting person states the sales were made under a Rule 10b5-1 trading plan adopted on November 15, 2024. Execution occurred in multiple trades at prices ranging from $92.49 to $94.25, with weighted average prices reported as $93.0449 and $93.7434. The Form 4 was signed by an attorney-in-fact on 10/02/2025.